The Evaluation Results of Proposed Antigen Rapid Diagnostic Tests for COVID-19: Some Possible Factors Might Influence

preprint OA: gold CC-BY-4.0
📄 Open PDF View at publisher

Abstract

Purpose: In addition to existing gold standard qRT-PCR methods, it needs to develop reliable rapid tests for infection control with early notification of COVID-19 cases to enable effective outbreak management. We evaluated the validity of the three Ag-RDT kits proposed by some companies in different countries by using qRT-PCR and analyzed its results. Methods: Each of the three Ag-RDT kits (namely A, B, C) was tested with 90 samples, consisting of samples with Ct ≤ 25, samples with Ct > 25, and negative SARS-CoV-2 PCR samples. Results: This study showed that for samples with Ct >25, all the three kits could not detect SARS-CoV-2 Ag (0% sensitivity) but they showed 100% specificity. Meanwhile, for samples with Ct ≤ 25, the kit C was the best (76.7% sensitivity and 100% specificity). The PPV of the three kits was 100%, but their NPV ranged 63% - 84.8%. The kit C showed the best accuracy (89.9%). Some factors might influence the results of evaluation such as variation of virus proteins and transportation-storage of the kits. Conclusion: The overall specificity of the three kits for all samples was high, however all of them have not met the minimum performance requirements of ≥ 80% sensitivity for samples with Ct ≤ 25. The validation test is very necessary to be carried out by the authority in national healthcare to ensure the feasibility of the kit for POCT of COVID-19. Some factors that might influence should be anticipated to increase their sensitivities and specificities.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0